These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 13716702)
21. [Case of aplastic anemia (panmyelophthisis or pancytopenia) after prolonged use of chloramphenicol (chloromycetin)]. KOSTER M; GROEN J Ned Tijdschr Geneeskd; 1953 Jun; 97(25):1590-5. PubMed ID: 13087410 [No Abstract] [Full Text] [Related]
22. Detection and prevention of drug-induced blood dyscrasias. ERSLEV AJ; WINTROBE MM JAMA; 1962 Jul; 181():114-9. PubMed ID: 13890697 [No Abstract] [Full Text] [Related]
23. [Drug cytopenia of allergic origin]. DREYFUS B Presse Med (1893); 1959 Aug; 67():1464-6. PubMed ID: 13818097 [No Abstract] [Full Text] [Related]
24. [Dangers of various therapeutic agents. Value of control of the blood formula]. BENOIST F Sem Hop Ther Paris; 1961 Jul; 37():605-7. PubMed ID: 13867328 [No Abstract] [Full Text] [Related]
25. Principles of pharmacotherapy: IV. Hematologic drug reactions. Pallasch TJ Anesth Prog; 1989; 36(1):1-4. PubMed ID: 2690677 [No Abstract] [Full Text] [Related]
26. Blood dyscrasias due to phenothiazine derivatives; report of four cases. PETERSEN MC; CAREY B; RHOADS DV Am J Psychiatry; 1958 Sep; 115(3):257-8. PubMed ID: 13571452 [No Abstract] [Full Text] [Related]
28. Erythrocythemia in primary carcinoma of the liver. A case report. ESCOBAR MA; TROBAUGH FE Arch Intern Med; 1962 Sep; 110():339-44. PubMed ID: 13890738 [No Abstract] [Full Text] [Related]
29. [Acquisitions and problems in the field of saturnine blood diseases]. PAOLINO W Arch Sci Med (Torino); 1960 Jan; 109():23-32. PubMed ID: 14430234 [No Abstract] [Full Text] [Related]
30. [Immunological aspects in pathogenesis of leukocytopathies and megakaryocytopathies]. ALEKSANDROWICZ J; GAERTNER H; PALESTER M Pol Arch Med Wewn; 1956; 26(11):1661-76. PubMed ID: 13419724 [No Abstract] [Full Text] [Related]
31. [Viruses in relation to the etiopathogenetic problem of neoplasms and malignant blood diseases of mammals]. MAGRASSI F Minerva Med; 1959 Dec; 50():4339-49. PubMed ID: 14419915 [No Abstract] [Full Text] [Related]
32. [Interpretation of hematological modifications secondary to x-ray exposure]. DENOLIN-REUBENS R; BASTENIER H; MELOT G J Belge Radiol; 1958; 41(3):365-74. PubMed ID: 13598723 [No Abstract] [Full Text] [Related]
33. Introduction: drug induced diseases I. Saltiel M J Pharm Pract; 2014 Oct; 27(5):429. PubMed ID: 25249587 [No Abstract] [Full Text] [Related]
34. [Side effects of drugs]. von Kress HF Munch Med Wochenschr; 1968 Aug; 110(35):1905-12. PubMed ID: 5695701 [No Abstract] [Full Text] [Related]
35. [Iatrogenic diseases in diseases of the blood and hematopoietic organs]. Capriles TV; Ettedgui HW Rev Venez Sanid Asist Soc; 1968; 33(1):65-75. PubMed ID: 5745397 [No Abstract] [Full Text] [Related]
36. The systemic importance of relative liver dysfunction to the development and specific treatment of vascular and blood diseases. A review of ten years of investigation. ISENSTEAD JH Am J Gastroenterol; 1960 Jun; 33():718-33. PubMed ID: 14405889 [No Abstract] [Full Text] [Related]
37. Drug-induced blood dyscrasias. WEIL PG Can Med Assoc J; 1962 Sep; 87(13):685-9. PubMed ID: 14005657 [TBL] [Abstract][Full Text] [Related]
38. The hand on the trigger needs precise aim. Gleeson SP; Brilli RJ J Pediatr; 2014 Sep; 165(3):432-4. PubMed ID: 24928696 [No Abstract] [Full Text] [Related]